These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15069989)

  • 1. The cultural shift in Italy's pharmaceutical policy in 1994: a case history.
    Garattini S
    J Ambul Care Manage; 2004; 27(2):120-6. PubMed ID: 15069989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultural shift in Italy's drug policy.
    Garattini S
    Lancet; 1995 Jul; 346(8966):5-6. PubMed ID: 7603156
    [No Abstract]   [Full Text] [Related]  

  • 3. [Impact Reimbursement Act on the pharmaceutical market in Poland].
    Giermaziak W
    Pol Merkur Lekarski; 2014 Apr; 36(214):270-3. PubMed ID: 24868902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical companies and Italian Regional Governments: managing relationships in an increasing institutional complexity.
    Compagni A; Cavalli L; Jommi C
    Health Policy; 2008 Sep; 87(3):333-41. PubMed ID: 18384907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Policy in Latvia.
    Silins J; Szkultecka-Dębek M
    Value Health Reg Issues; 2017 Sep; 13():73-78. PubMed ID: 29073995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Policy of the Italian Government in the Discovery, Development, and Access to Medicines.
    Scavone C; Carnovale C; Ruggiero R; Radice S; Scatigna M; Racagni G; Mugelli A; Rossi F; Clementi E; Capuano A
    Clin Ther; 2018 Nov; 40(11):1931-1940. PubMed ID: 30458933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Early achievements of the Danish pharmaceutical industry-7].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2014; (42):31-62. PubMed ID: 25816561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
    Morgan S; McMahon M; Greyson D
    Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic drug use in Italy, 1984-99: the impact of a change in reimbursement status.
    Barbui C; Campomori A; Mezzalira L; Lopatriello S; Cas RD; Garattini S
    Int Clin Psychopharmacol; 2001 Jul; 16(4):227-33. PubMed ID: 11459337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The strategic interaction between firms and formulary committees: effects on the prices of new drugs.
    García-Alonso MD; García-Mariñoso B
    J Health Econ; 2008 Mar; 27(2):377-404. PubMed ID: 18276026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Policy in Bulgaria.
    Dimova A; Rohova M; Atanasova E; Kawalec P; Czok K
    Value Health Reg Issues; 2017 Sep; 13():50-54. PubMed ID: 29073988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002.
    Andersson K; Petzold MG; Sonesson C; Lönnroth K; Carlsten A
    Health Policy; 2006 Dec; 79(2-3):231-43. PubMed ID: 16473436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future European health care: cost containment, health care reform and scientific progress in drug research.
    Emilien G
    Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical prescriptions in Italy.
    Garattini S
    Int J Technol Assess Health Care; 1995; 11(3):417-27. PubMed ID: 7591544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The healthcare system and the provision of oral healthcare in European Union member states. Part 8: Italy.
    Bindi M; Paganelli C; Eaton KA; Widström E
    Br Dent J; 2017 May; 222(10):809-817. PubMed ID: 28546591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. So much time for so little: Italy's pharmaceutical industry and doctors' information needs.
    Maestri E; Furlani G; Suzzi F; Campomori A; Formoso G; Magrini N
    BMJ; 2000 Jan; 320(7226):55-6. PubMed ID: 10617540
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug Policy in Estonia.
    Mägi K; Lepaste M; Szkultecka-Dębek M
    Value Health Reg Issues; 2018 Sep; 16():1-4. PubMed ID: 29529444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Italy: health system review.
    Ferre F; de Belvis AG; Valerio L; Longhi S; Lazzari A; Fattore G; Ricciardi W; Maresso A
    Health Syst Transit; 2014; 16(4):1-168. PubMed ID: 25471543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.